Last reviewed · How we verify

Dried Ferrous Sulfate

Korea University Guro Hospital · FDA-approved active Small molecule Quality 5/100

Dried Ferrous Sulfate is a Small molecule drug developed by Korea University Guro Hospital. It is currently FDA-approved.

Dried Ferrous Sulfate, marketed by Korea University Guro Hospital, is an established treatment in the iron deficiency anemia market. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports current market positioning. The primary risk lies in potential generic competition post-patent expiry, which could erode market share and revenue.

At a glance

Generic nameDried Ferrous Sulfate
SponsorKorea University Guro Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Dried Ferrous Sulfate

What is Dried Ferrous Sulfate?

Dried Ferrous Sulfate is a Small molecule drug developed by Korea University Guro Hospital.

Who makes Dried Ferrous Sulfate?

Dried Ferrous Sulfate is developed and marketed by Korea University Guro Hospital (see full Korea University Guro Hospital pipeline at /company/korea-university-guro-hospital).

What development phase is Dried Ferrous Sulfate in?

Dried Ferrous Sulfate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing